Core Viewpoint - The company is committed to a health-focused product strategy, emphasizing the growth of its key products and plans for shareholder returns [1][2]. Financial Performance - In 2024, the company achieved revenue of 2.412 billion yuan, a year-on-year increase of 16.79% [1] - The net profit attributable to shareholders reached 291 million yuan, up 39.01% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 261 million yuan, reflecting a 39.91% increase [1] Strategic Focus - The company is implementing a health-oriented "big single product" strategy, which has led to significant sales growth and market recognition [1][2] - The company has launched multiple innovative products in 2024, supported by various research platforms to enhance product competitiveness [1] Market Positioning - The company has established partnerships with over 100 snack specialty channels, covering more than 35,000 terminal stores, with this channel's revenue growing over 100% year-on-year [2] - The company emphasizes the importance of product quality and consumer education in driving sales and market growth [2] Shareholder Returns - The company plans to distribute a cash dividend of 3 yuan per 10 shares, totaling 179 million yuan, which is 61% of the net profit attributable to shareholders [2] - The company has a three-year dividend return plan, committing to distribute at least 20% of the annual distributable profit in cash if conditions allow [3] - Since its IPO, the company has distributed over 590 million yuan in dividends, significantly exceeding its initial fundraising amount [3]
劲仔食品持续推动健康大单品战略 以高分红回报投资者